-
1
-
-
41749101957
-
Pathogenesis of thrombotic microangiopathies
-
Zheng XL, Sadler JE. Pathogenesis of thrombotic microangiopathies. Annu Rev Pathol. 2008;3:249-277.
-
(2008)
Annu Rev Pathol.
, vol.3
, pp. 249-277
-
-
Zheng, X.L.1
Sadler, J.E.2
-
2
-
-
0035807348
-
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
-
Levy GG, Nichols WC, Lian EC, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 2001;413(6855):488-494.
-
(2001)
Nature
, vol.413
, Issue.6855
, pp. 488-494
-
-
Levy, G.G.1
Nichols, W.C.2
Lian, E.C.3
-
3
-
-
0032569840
-
Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura
-
Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998;339(22):1585-1594.
-
(1998)
N Engl J Med.
, vol.339
, Issue.22
, pp. 1585-1594
-
-
Tsai, H.M.1
Lian, E.C.2
-
4
-
-
84864041240
-
Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura
-
Lotta LA, Wu HM, Mackie IJ, et al. Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura. Blood. 2012;120(2):440-448.
-
(2012)
Blood
, vol.120
, Issue.2
, pp. 440-448
-
-
Lotta, L.A.1
Wu, H.M.2
Mackie, I.J.3
-
5
-
-
33947594746
-
Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity
-
French Clinical and Biological Network on Adult Thrombotic Microangiopathies
-
Ferrari S, Scheiflinger F, Rieger M, et al; French Clinical and Biological Network on Adult Thrombotic Microangiopathies. Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activity. Blood. 2007;109(7):2815-2822.
-
(2007)
Blood
, vol.109
, Issue.7
, pp. 2815-2822
-
-
Ferrari, S.1
Scheiflinger, F.2
Rieger, M.3
-
6
-
-
40849114959
-
ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission
-
Peyvandi F, Lavoretano S, Palla R, et al. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission. Haematologica. 2008;93(2):232-239.
-
(2008)
Haematologica
, vol.93
, Issue.2
, pp. 232-239
-
-
Peyvandi, F.1
Lavoretano, S.2
Palla, R.3
-
7
-
-
67049172151
-
Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: A mechanism associated with sickle cell disease
-
Zhou Z, Han H, Cruz MA, López JA, Dong JF, Guchhait P. Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease. Thromb Haemost. 2009;101(6):1070-1077.
-
(2009)
Thromb Haemost
, vol.101
, Issue.6
, pp. 1070-1077
-
-
Zhou, Z.1
Han, H.2
Cruz, M.A.3
López, J.A.4
Dong, J.F.5
Guchhait, P.6
-
8
-
-
11244281582
-
Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: In vitro inhibition of ADAMTS13 activity by hemoglobin
-
Studt JD, Kremer Hovinga JA, Antoine G, et al. Fatal congenital thrombotic thrombocytopenic purpura with apparent ADAMTS13 inhibitor: in vitro inhibition of ADAMTS13 activity by hemoglobin. Blood. 2005;105(2):542-544.
-
(2005)
Blood
, vol.105
, Issue.2
, pp. 542-544
-
-
Studt, J.D.1
Kremer Hovinga, J.A.2
Antoine, G.3
-
9
-
-
84930181394
-
Unconjugated bilirubin inhibits proteolytic cleavage of von Willebrand factor by ADAMTS13 protease
-
Lu RN, Yang S, Wu HM, Zheng XL. Unconjugated bilirubin inhibits proteolytic cleavage of von Willebrand factor by ADAMTS13 protease. J Thromb Haemost. 2015;13(6):1064-1072.
-
(2015)
J Thromb Haemost
, vol.13
, Issue.6
, pp. 1064-1072
-
-
Lu, R.N.1
Yang, S.2
Wu, H.M.3
Zheng, X.L.4
-
10
-
-
77950563514
-
Influenza A infection triggers thrombotic thrombocytopenic purpura by producing the anti-ADAMTS13 IgG inhibitor
-
Kosugi N, Tsurutani Y, Isonishi A, Hori Y, Matsumoto M, Fujimura Y. Influenza A infection triggers thrombotic thrombocytopenic purpura by producing the anti-ADAMTS13 IgG inhibitor. Intern Med. 2010;49(7):689-693.
-
(2010)
Intern Med.
, vol.49
, Issue.7
, pp. 689-693
-
-
Kosugi, N.1
Tsurutani, Y.2
Isonishi, A.3
Hori, Y.4
Matsumoto, M.5
Fujimura, Y.6
-
11
-
-
33645989193
-
Thrombotic thrombocytopenic purpura secondary to Streptococcus
-
Morrin MJ, Jones FG, McConville J, et al. Thrombotic thrombocytopenic purpura secondary to Streptococcus. Transfus Apheresis Sci. 2006;34(2):153-155.
-
(2006)
Transfus Apheresis Sci.
, vol.34
, Issue.2
, pp. 153-155
-
-
Morrin, M.J.1
Jones, F.G.2
McConville, J.3
-
12
-
-
77950833468
-
Infection frequently triggers thrombotic microangiopathy in patients with preexisting risk factors: A single-institution experience
-
Douglas KW, Pollock KG, Young D, Catlow J, Green R. Infection frequently triggers thrombotic microangiopathy in patients with preexisting risk factors: a single-institution experience. J Clin Apher. 2010;25(2):47-53.
-
(2010)
J Clin Apher
, vol.25
, Issue.2
, pp. 47-53
-
-
Douglas, K.W.1
Pollock, K.G.2
Young, D.3
Catlow, J.4
Green, R.5
-
13
-
-
83655193502
-
α-Defensins in human innate immunity
-
Lehrer RI, Lu W. α-Defensins in human innate immunity. Immunol Rev. 2012;245(1):84-112.
-
(2012)
Immunol Rev.
, vol.245
, Issue.1
, pp. 84-112
-
-
Lehrer, R.I.1
Lu, W.2
-
14
-
-
0027237329
-
Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis
-
Panyutich AV, Panyutich EA, Krapivin VA, Baturevich EA, Ganz T. Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis. J Lab Clin Med. 1993;122(2):202-207.
-
(1993)
J Lab Clin Med.
, vol.122
, Issue.2
, pp. 202-207
-
-
Panyutich, A.V.1
Panyutich, E.A.2
Krapivin, V.A.3
Baturevich, E.A.4
Ganz, T.5
-
15
-
-
63849149870
-
High alpha-defensin levels in patients with systemic lupus erythematosus
-
Sthoeger ZM, Bezalel S, Chapnik N, Asher I, Froy O. High alpha-defensin levels in patients with systemic lupus erythematosus. Immunology. 2009;127(1):116-122.
-
(2009)
Immunology
, vol.127
, Issue.1
, pp. 116-122
-
-
Sthoeger, Z.M.1
Bezalel, S.2
Chapnik, N.3
Asher, I.4
Froy, O.5
-
16
-
-
84859169216
-
Human neutrophil alpha-defensins induce formation of fibrinogen and thrombospondin-1 amyloid-like structures and activate platelets via glycoprotein IIb/IIIa
-
Horn M, Bertling A, Brodde MF, et al. Human neutrophil alpha-defensins induce formation of fibrinogen and thrombospondin-1 amyloid-like structures and activate platelets via glycoprotein IIb/IIIa. J Thromb Haemost. 2012;10(4):647-661.
-
(2012)
J Thromb Haemost
, vol.10
, Issue.4
, pp. 647-661
-
-
Horn, M.1
Bertling, A.2
Brodde, M.F.3
-
17
-
-
0029892845
-
Defensin modulates tissue-type plasminogen activator and plasminogen binding to fibrin and endothelial cells
-
Higazi AA, Ganz T, Kariko K, Cines DB. Defensin modulates tissue-type plasminogen activator and plasminogen binding to fibrin and endothelial cells. J Biol Chem. 1996;271(30):17650-17655.
-
(1996)
J Biol Chem.
, vol.271
, Issue.30
, pp. 17650-17655
-
-
Higazi, A.A.1
Ganz, T.2
Kariko, K.3
Cines, D.B.4
-
18
-
-
0027980251
-
Neutrophil defensins: Purification, characterization, and antimicrobial testing
-
Harwig SS, Ganz T, Lehrer RI. Neutrophil defensins: purification, characterization, and antimicrobial testing. Methods Enzymol. 1994;236:160-172.
-
(1994)
Methods Enzymol.
, vol.236
, pp. 160-172
-
-
Harwig, S.S.1
Ganz, T.2
Lehrer, R.I.3
-
19
-
-
0026609053
-
Characterization of defensin precursors in mature human neutrophils
-
Harwig SS, Park AS, Lehrer RI. Characterization of defensin precursors in mature human neutrophils. Blood. 1992;79(6):1532-1537.
-
(1992)
Blood
, vol.79
, Issue.6
, pp. 1532-1537
-
-
Harwig, S.S.1
Park, A.S.2
Lehrer, R.I.3
-
20
-
-
79955643808
-
Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies
-
Plaimauer B, Kremer Hovinga JA, Juno C, et al. Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies. J Thromb Haemost. 2011;9(5):936-944.
-
(2011)
J Thromb Haemost
, vol.9
, Issue.5
, pp. 936-944
-
-
Plaimauer, B.1
Kremer Hovinga, J.A.2
Juno, C.3
-
21
-
-
0037111571
-
Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13)
-
Plaimauer B, Zimmermann K, Völkel D, et al. Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13). Blood. 2002;100(10):3626-3632.
-
(2002)
Blood
, vol.100
, Issue.10
, pp. 3626-3632
-
-
Plaimauer, B.1
Zimmermann, K.2
Völkel, D.3
-
22
-
-
34548834974
-
The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flow
-
Zhang P, Pan W, Rux AH, Sachais BS, Zheng XL. The cooperative activity between the carboxyl-terminal TSP1 repeats and the CUB domains of ADAMTS13 is crucial for recognition of von Willebrand factor under flow. Blood. 2007;110(6):1887-1894.
-
(2007)
Blood
, vol.110
, Issue.6
, pp. 1887-1894
-
-
Zhang, P.1
Pan, W.2
Rux, A.H.3
Sachais, B.S.4
Zheng, X.L.5
-
23
-
-
77956514337
-
Factor VIII and platelets synergistically accelerate cleavage of von Willebrand factor by ADAMTS13 under fluid shear stress
-
Skipwith CG, Cao W, Zheng XL. Factor VIII and platelets synergistically accelerate cleavage of von Willebrand factor by ADAMTS13 under fluid shear stress. J Biol Chem. 2010;285(37):28596-28603.
-
(2010)
J Biol Chem.
, vol.285
, Issue.37
, pp. 28596-28603
-
-
Skipwith, C.G.1
Cao, W.2
Zheng, X.L.3
-
24
-
-
33750000959
-
Creation of a recombinant peptide substrate for fluorescence resonance energy transfer-based protease assays
-
Zhang L, Lawson HL, Harish VC, Huff JD, Knovich MA, Owen J. Creation of a recombinant peptide substrate for fluorescence resonance energy transfer-based protease assays. Anal Biochem. 2006;358(2):298-300.
-
(2006)
Anal Biochem.
, vol.358
, Issue.2
, pp. 298-300
-
-
Zhang, L.1
Lawson, H.L.2
Harish, V.C.3
Huff, J.D.4
Knovich, M.A.5
Owen, J.6
-
25
-
-
70349569566
-
Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site
-
Raife TJ, Cao W, Atkinson BS, et al. Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site. Blood. 2009;114(8):1666-1674.
-
(2009)
Blood
, vol.114
, Issue.8
, pp. 1666-1674
-
-
Raife, T.J.1
Cao, W.2
Atkinson, B.S.3
-
26
-
-
23844465898
-
The proximal carboxyl-terminal domains of ADAMTS13 determine substrate specificity and are all required for cleavage of von Willebrand factor
-
Ai J, Smith P, Wang S, Zhang P, Zheng XL. The proximal carboxyl-terminal domains of ADAMTS13 determine substrate specificity and are all required for cleavage of von Willebrand factor. J Biol Chem. 2005;280(33):29428-29434.
-
(2005)
J Biol Chem.
, vol.280
, Issue.33
, pp. 29428-29434
-
-
Ai, J.1
Smith, P.2
Wang, S.3
Zhang, P.4
Zheng, X.L.5
-
27
-
-
80052968358
-
Essential domains of a disintegrin and metalloprotease with thrombospondin type 1 repeats-13 metalloprotease required for modulation of arterial thrombosis
-
Xiao J, Jin SY, Xue J, Sorvillo N, Voorberg J, Zheng XL. Essential domains of a disintegrin and metalloprotease with thrombospondin type 1 repeats-13 metalloprotease required for modulation of arterial thrombosis. Arterioscler Thromb Vasc Biol. 2011;31(10):2261-2269.
-
(2011)
Arterioscler Thromb Vasc Biol.
, vol.31
, Issue.10
, pp. 2261-2269
-
-
Xiao, J.1
Jin, S.Y.2
Xue, J.3
Sorvillo, N.4
Voorberg, J.5
Zheng, X.L.6
-
28
-
-
77950414918
-
Amino acid residues Arg(659), Arg(660), and Tyr(661) in the spacer domain of ADAMTS13 are critical for cleavage of von Willebrand factor
-
Jin SY, Skipwith CG, Zheng XL. Amino acid residues Arg(659), Arg(660), and Tyr(661) in the spacer domain of ADAMTS13 are critical for cleavage of von Willebrand factor. Blood. 2010;115(11):2300-2310.
-
(2010)
Blood
, vol.115
, Issue.11
, pp. 2300-2310
-
-
Jin, S.Y.1
Skipwith, C.G.2
Zheng, X.L.3
-
29
-
-
0025903814
-
Crystal structure of defensin HNP-3, an amphiphilic dimer: Mechanisms of membrane permeabilization
-
Hill CP, Yee J, Selsted ME, Eisenberg D. Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science. 1991;251(5000):1481-1485.
-
(1991)
Science
, vol.251
, Issue.5000
, pp. 1481-1485
-
-
Hill, C.P.1
Yee, J.2
Selsted, M.E.3
Eisenberg, D.4
-
30
-
-
84900450913
-
Hydrophobic determinants of α-defensin bactericidal activity
-
Tai KP, Le VV, Selsted ME, Ouellette AJ. Hydrophobic determinants of α-defensin bactericidal activity. Infect Immun. 2014;82(6):2195-2202.
-
(2014)
Infect Immun.
, vol.82
, Issue.6
, pp. 2195-2202
-
-
Tai, K.P.1
Le, V.V.2
Selsted, M.E.3
Ouellette, A.J.4
-
31
-
-
57049188278
-
Human neutrophil peptides: A novel potential mediator of inflammatory cardiovascular diseases
-
Quinn K, Henriques M, Parker T, Slutsky AS, Zhang H. Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases. Am J Physiol Heart Circ Physiol. 2008;295(5):H1817-H1824.
-
(2008)
Am J Physiol Heart Circ Physiol.
, vol.295
, Issue.5
, pp. H1817-H1824
-
-
Quinn, K.1
Henriques, M.2
Parker, T.3
Slutsky, A.S.4
Zhang, H.5
-
32
-
-
32344453825
-
Neutrophil antimicrobial peptide alpha-defensin causes endothelial dysfunction in porcine coronary arteries
-
Kougias P, Chai H, Lin PH, Yao Q, Lumsden AB, Chen C. Neutrophil antimicrobial peptide alpha-defensin causes endothelial dysfunction in porcine coronary arteries. J Vasc Surg. 2006;43(2):357-363.
-
(2006)
J Vasc Surg.
, vol.43
, Issue.2
, pp. 357-363
-
-
Kougias, P.1
Chai, H.2
Lin, P.H.3
Yao, Q.4
Lumsden, A.B.5
Chen, C.6
-
33
-
-
84958214666
-
α-Defensins induce a post-translational modification of low density lipoprotein (LDL) that promotes atherosclerosis at normal levels of plasma cholesterol
-
Abu-Fanne R, Maraga E, Abd-Elrahman I, et al. α-Defensins induce a post-translational modification of low density lipoprotein (LDL) that promotes atherosclerosis at normal levels of plasma cholesterol. J Biol Chem. 2016;291(6):2777-2786.
-
(2016)
J Biol Chem.
, vol.291
, Issue.6
, pp. 2777-2786
-
-
Abu-Fanne, R.1
Maraga, E.2
Abd-Elrahman, I.3
-
34
-
-
52649182049
-
Extensive contacts between ADAMTS13 exosites and von Willebrand factor domain A2 contribute to substrate specificity
-
Gao W, Anderson PJ, Sadler JE. Extensive contacts between ADAMTS13 exosites and von Willebrand factor domain A2 contribute to substrate specificity. Blood. 2008;112(5):1713-1719.
-
(2008)
Blood
, vol.112
, Issue.5
, pp. 1713-1719
-
-
Gao, W.1
Anderson, P.J.2
Sadler, J.E.3
-
35
-
-
84858591438
-
Sometimes it takes two to tango: Contributions of dimerization to functions of human α-defensin HNP1 peptide
-
Pazgier M, Wei G, Ericksen B, et al. Sometimes it takes two to tango: contributions of dimerization to functions of human α-defensin HNP1 peptide. J Biol Chem. 2012;287(12):8944-8953.
-
(2012)
J Biol Chem.
, vol.287
, Issue.12
, pp. 8944-8953
-
-
Pazgier, M.1
Wei, G.2
Ericksen, B.3
-
36
-
-
84864643012
-
Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies
-
Fuchs TA, Kremer Hovinga JA, Schatzberg D, Wagner DD, Lämmle B. Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood. 2012;120(6):1157-1164.
-
(2012)
Blood
, vol.120
, Issue.6
, pp. 1157-1164
-
-
Fuchs, T.A.1
Kremer Hovinga, J.A.2
Schatzberg, D.3
Wagner, D.D.4
Lämmle, B.5
-
37
-
-
0030785439
-
Elevated concentrations of human neutrophil peptides in plasma, blood, and body fluids from patients with infections
-
Ihi T, Nakazato M, Mukae H, Matsukura S. Elevated concentrations of human neutrophil peptides in plasma, blood, and body fluids from patients with infections. Clin Infect Dis. 1997;25(5):1134-1140.
-
(1997)
Clin Infect Dis.
, vol.25
, Issue.5
, pp. 1134-1140
-
-
Ihi, T.1
Nakazato, M.2
Mukae, H.3
Matsukura, S.4
-
38
-
-
51049108127
-
ADAMTS13: A new link between thrombosis and inflammation
-
Chauhan AK, Kisucka J, Brill A, Walsh MT, Scheiflinger F, Wagner DD. ADAMTS13: a new link between thrombosis and inflammation. J Exp Med. 2008;205(9):2065-2074.
-
(2008)
J Exp Med.
, vol.205
, Issue.9
, pp. 2065-2074
-
-
Chauhan, A.K.1
Kisucka, J.2
Brill, A.3
Walsh, M.T.4
Scheiflinger, F.5
Wagner, D.D.6
-
39
-
-
33645090687
-
Systemic antithrombotic effects of ADAMTS13
-
Chauhan AK, Motto DG, Lamb CB, et al. Systemic antithrombotic effects of ADAMTS13. J Exp Med. 2006;203(3):767-776.
-
(2006)
J Exp Med.
, vol.203
, Issue.3
, pp. 767-776
-
-
Chauhan, A.K.1
Motto, D.G.2
Lamb, C.B.3
-
40
-
-
84938900181
-
High-resolution epitope mapping by HX MS reveals the pathogenic mechanism and a possible therapy for autoimmune TTP syndrome
-
Casina VC, Hu W, Mao JH, et al. High-resolution epitope mapping by HX MS reveals the pathogenic mechanism and a possible therapy for autoimmune TTP syndrome. Proc Natl Acad Sci USA. 2015;112(31):9620-9625.
-
(2015)
Proc Natl Acad Sci USA
, vol.112
, Issue.31
, pp. 9620-9625
-
-
Casina, V.C.1
Hu, W.2
Mao, J.H.3
-
41
-
-
0030038197
-
Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils
-
Chertov O, Michiel DF, Xu L, et al. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem. 1996;271(6):2935-2940.
-
(1996)
J Biol Chem.
, vol.271
, Issue.6
, pp. 2935-2940
-
-
Chertov, O.1
Michiel, D.F.2
Xu, L.3
-
42
-
-
0033844287
-
Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells
-
Yang D, Chen Q, Chertov O, Oppenheim JJ. Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J Leukoc Biol. 2000;68(1):9-14.
-
(2000)
J Leukoc Biol.
, vol.68
, Issue.1
, pp. 9-14
-
-
Yang, D.1
Chen, Q.2
Chertov, O.3
Oppenheim, J.J.4
-
43
-
-
84867997580
-
STEC-HUS, atypical HUS and TTP are all diseases of complement activation
-
Noris M, Mescia F, Remuzzi G. STEC-HUS, atypical HUS and TTP are all diseases of complement activation. Nat Rev Nephrol. 2012;8(11):622-633.
-
(2012)
Nat Rev Nephrol
, vol.8
, Issue.11
, pp. 622-633
-
-
Noris, M.1
Mescia, F.2
Remuzzi, G.3
-
44
-
-
84885339216
-
Complement activation and mortality during an acute episode of thrombotic thrombocytopenic purpura
-
Wu TC, Yang S, Haven S, et al. Complement activation and mortality during an acute episode of thrombotic thrombocytopenic purpura. J Thromb Haemost. 2013;11(10):1925-1927.
-
(2013)
J Thromb Haemost
, vol.11
, Issue.10
, pp. 1925-1927
-
-
Wu, T.C.1
Yang, S.2
Haven, S.3
-
45
-
-
84894705729
-
Complement and cytokine response in acute thrombotic thrombocytopenic purpura
-
Westwood JP, Langley K, Heelas E, Machin SJ, Scully M. Complement and cytokine response in acute thrombotic thrombocytopenic purpura. Br J Haematol. 2014;164(6):858-866.
-
(2014)
Br J Haematol.
, vol.164
, Issue.6
, pp. 858-866
-
-
Westwood, J.P.1
Langley, K.2
Heelas, E.3
Machin, S.J.4
Scully, M.5
-
46
-
-
77952310993
-
Neutrophil alpha-defensins cause lung injury by disrupting the capillary-epithelial barrier
-
Bdeir K, Higazi AA, Kulikovskaya I, et al. Neutrophil alpha-defensins cause lung injury by disrupting the capillary-epithelial barrier. Am J Respir Crit Care Med. 2010;181(9):935-946.
-
(2010)
Am J Respir Crit Care Med.
, vol.181
, Issue.9
, pp. 935-946
-
-
Bdeir, K.1
Higazi, A.A.2
Kulikovskaya, I.3
-
47
-
-
84864280369
-
Genetic ablation of Adamts13 gene dramatically accelerates the formation of early atherosclerosis in a murine model
-
Jin SY, Tohyama J, Bauer RC, Cao NN, Rader DJ, Zheng XL. Genetic ablation of Adamts13 gene dramatically accelerates the formation of early atherosclerosis in a murine model. Arterioscler Thromb Vasc Biol. 2012;32(8):1817-1823.
-
(2012)
Arterioscler Thromb Vasc Biol.
, vol.32
, Issue.8
, pp. 1817-1823
-
-
Jin, S.Y.1
Tohyama, J.2
Bauer, R.C.3
Cao, N.N.4
Rader, D.J.5
Zheng, X.L.6
-
48
-
-
84880468014
-
AAV-mediated expression of an ADAMTS13 variant prevents shigatoxin-induced thrombotic thrombocytopenic purpura
-
Jin SY, Xiao J, Bao J, et al. AAV-mediated expression of an ADAMTS13 variant prevents shigatoxin-induced thrombotic thrombocytopenic purpura. Blood. 2013;121(19):3825-3829.
-
(2013)
Blood
, vol.121
, Issue.19
, pp. 3825-3829
-
-
Jin, S.Y.1
Xiao, J.2
Bao, J.3
|